BACKGROUND: Measuring the rate of clearance of carbon-11 labelled acetate from myocardium using positron emission tomography (PET) is an accepted technique for noninvasively assessing myocardial oxygen consumption. Initial myocardial uptake of [(11)C]acetate, however, is related to myocardial blood flow (MBF) and several tracer kinetic models for quantifying MBF using [(11)C]acetate have been proposed. The objective of this study was to assess these models. METHODS: Eighteen healthy subjects and 18 patients with hypertrophic cardiomyopathy (HCM) were studied under baseline conditions with [(11)C]acetate and [(15)O]water. Four previously reported methods, including single- and multi-tissue compartment models, were used to calculate MBF from the measured [(11)C]acetate rate of influx K (1) and the (previously) reported relationship between K (1) and MBF. These MBF values were then compared with those derived from corresponding [(15)O]water studies. RESULTS: For all models, correlations between [(11)C]acetate and [(15)O]water-derived MBF ranged from .67 to .86 (all P < .005) in the control group and from .73 to .85 (all P < .001) in the HCM group. Two out of four models systematically underestimated perfusion with [(11)C]acetate, whilst the third model resulted in an overestimation. The fourth model, based on a simple single tissue compartment model with spillover, partial volume and recirculating metabolite corrections, resulted in a regression equation with a slope of near unity and an Y-intercept of almost zero (controls, K(1) = .74[MBF] + .09, r = .86, SEE = .13, P < .001 and HCM, K(1) = .89[MBF] + .03, r = .85, SEE = .12, P < .001). CONCLUSION: [(11)C]acetate enables quantification of MBF in fairly good agreement with actual MBF in both healthy individuals and patients with HCM. A single tissue compartment model with standardized correction for recirculating metabolites and with corrections for partial volume and spillover provided the best results.
BACKGROUND: Measuring the rate of clearance of carbon-11 labelled acetate from myocardium using positron emission tomography (PET) is an accepted technique for noninvasively assessing myocardial oxygen consumption. Initial myocardial uptake of [(11)C]acetate, however, is related to myocardial blood flow (MBF) and several tracer kinetic models for quantifying MBF using [(11)C]acetate have been proposed. The objective of this study was to assess these models. METHODS: Eighteen healthy subjects and 18 patients with hypertrophic cardiomyopathy (HCM) were studied under baseline conditions with [(11)C]acetate and [(15)O]water. Four previously reported methods, including single- and multi-tissue compartment models, were used to calculate MBF from the measured [(11)C]acetate rate of influx K (1) and the (previously) reported relationship between K (1) and MBF. These MBF values were then compared with those derived from corresponding [(15)O]water studies. RESULTS: For all models, correlations between [(11)C]acetate and [(15)O]water-derived MBF ranged from .67 to .86 (all P < .005) in the control group and from .73 to .85 (all P < .001) in the HCM group. Two out of four models systematically underestimated perfusion with [(11)C]acetate, whilst the third model resulted in an overestimation. The fourth model, based on a simple single tissue compartment model with spillover, partial volume and recirculating metabolite corrections, resulted in a regression equation with a slope of near unity and an Y-intercept of almost zero (controls, K(1) = .74[MBF] + .09, r = .86, SEE = .13, P < .001 and HCM, K(1) = .89[MBF] + .03, r = .85, SEE = .12, P < .001). CONCLUSION:[(11)C]acetate enables quantification of MBF in fairly good agreement with actual MBF in both healthy individuals and patients with HCM. A single tissue compartment model with standardized correction for recirculating metabolites and with corrections for partial volume and spillover provided the best results.
Authors: Paul Knaapen; Tjeerd Germans; Juhani Knuuti; Walter J Paulus; Pieter A Dijkmans; Cornelis P Allaart; Adriaan A Lammertsma; Frans C Visser Journal: Circulation Date: 2007-02-20 Impact factor: 29.690
Authors: J van den Hoff; W Burchert; A R Börner; H Fricke; G Kühnel; G J Meyer; D Otto; E Weckesser; H G Wolpers; W H Knapp Journal: J Nucl Med Date: 2001-08 Impact factor: 10.057
Authors: Pilar Herrero; Joonyoung Kim; Terry L Sharp; John A Engelbach; Jason S Lewis; Robert J Gropler; Michael J Welch Journal: J Nucl Med Date: 2006-03 Impact factor: 10.057
Authors: Paul Knaapen; Ronald Boellaard; Marco J W Götte; Pieter A Dijkmans; Linda M C van Campen; Carel C de Cock; Gert Luurtsema; Cees A Visser; Adriaan A Lammertsma; Frans C Visser Journal: J Nucl Med Date: 2004-08 Impact factor: 10.057
Authors: Paul Knaapen; Tjeerd Germans; Paolo G Camici; Ornella E Rimoldi; Folkert J ten Cate; Jurrien M ten Berg; Pieter A Dijkmans; Ronald Boellaard; Willem G van Dockum; Marco J W Götte; Jos W R Twisk; Albert C van Rossum; Adriaan A Lammertsma; Frans C Visser Journal: Am J Physiol Heart Circ Physiol Date: 2007-12-21 Impact factor: 4.733
Authors: Kai Yi Wu; Vincent Dinculescu; Jennifer M Renaud; Shin-Yee Chen; Ian G Burwash; Lisa M Mielniczuk; Rob S B Beanlands; Robert A deKemp Journal: J Nucl Cardiol Date: 2018-02-16 Impact factor: 5.952
Authors: Etienne Croteau; Jennifer M Renaud; Matthew McDonald; Ran Klein; Jean N DaSilva; Rob S B Beanlands; Robert A deKemp Journal: Eur J Nucl Med Mol Imaging Date: 2015-07-05 Impact factor: 9.236
Authors: K J Mather; G D Hutchins; K Perry; W Territo; R Chisholm; A Acton; B Glick-Wilson; R V Considine; S Moberly; T R DeGrado Journal: Am J Physiol Endocrinol Metab Date: 2016-01-05 Impact factor: 4.310
Authors: Ilaria Grassi; Cristina Nanni; Vincenzo Allegri; Joshua James Morigi; Gian Carlo Montini; Paolo Castellucci; Stefano Fanti Journal: Am J Nucl Med Mol Imaging Date: 2011-12-15
Authors: Etienne Croteau; Jennifer M Renaud; Christine Archer; Ran Klein; Jean N DaSilva; Terrence D Ruddy; Rob Sb Beanlands; Robert A deKemp Journal: EJNMMI Res Date: 2014-12-16 Impact factor: 3.138
Authors: Anu Autio; Sauli Uotila; Max Kiugel; Ville Kytö; Heidi Liljenbäck; Nobuyuki Kudomi; Vesa Oikonen; Olli Metsälä; Semi Helin; Juhani Knuuti; Antti Saraste; Anne Roivainen Journal: J Nucl Cardiol Date: 2019-05-29 Impact factor: 5.952